Published in J Thorac Cardiovasc Surg on July 12, 2007
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
Mesenchymal stem cells and cardiac repair. J Cell Mol Med (2008) 1.37
Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J Cell Mol Med (2010) 1.07
Vascular endoluminal delivery of mesenchymal stem cells using acoustic radiation force. Tissue Eng Part A (2011) 0.83
Stem cell therapy and tissue engineering for correction of congenital heart disease. Front Cell Dev Biol (2015) 0.79
Clinical results of implanted tissue engineered heart valves. HSR Proc Intensive Care Cardiovasc Anesth (2012) 0.78
Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application. J Mater Sci Mater Med (2011) 0.78
Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts. Heart Vessels (2016) 0.77
How to make a heart valve: from embryonic development to bioengineering of living valve substitutes. Cold Spring Harb Perspect Med (2014) 0.77
Heart valve tissue engineering: research should proceed along validated routes. J Thorac Cardiovasc Surg (2008) 0.77
Tissue-engineered heart valves: bioreactor--yes or no? J Thorac Cardiovasc Surg (2008) 0.75
PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab (2007) 7.19
Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med (2003) 5.33
Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med (2012) 4.37
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J (2007) 3.03
Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med (2012) 2.88
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet (2011) 2.88
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Arch Cardiovasc Dis (2013) 2.71
Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J (2010) 2.63
Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ Res (2011) 2.60
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol (2010) 2.52
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J (2007) 2.12
Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR. JACC Cardiovasc Imaging (2013) 2.10
Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients. Br J Haematol (2013) 2.03
Pivotal role of bedside Doppler echocardiography in the assessment of patients with acute heart failure and mitral regurgitation. Cardiology (2009) 2.03
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J (2004) 1.98
Medical advances in the treatment of postpartum hemorrhage. Anesth Analg (2014) 1.96
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J (2011) 1.93
Speckle tracking analysis allows sensitive detection of stress cardiomyopathy in severe aneurysmal subarachnoid hemorrhage patients. Intensive Care Med (2016) 1.80
Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J (2010) 1.71
Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res (2013) 1.66
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J (2005) 1.64
Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment. Circulation (2013) 1.58
Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation (2008) 1.56
Inferior vena cava agenesis and deep vein thrombosis: 10 patients and review of the literature. Vasc Med (2010) 1.56
Results of endoluminal occlusion of the inferior vena cava during radical nephrectomy and thrombectomy. Eur Urol (2008) 1.55
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J (2005) 1.53
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J (2005) 1.52
Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis (2010) 1.52
Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J Thorac Cardiovasc Surg (2006) 1.46
Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg (2008) 1.45
Mid-ventricular ballooning heart syndrome. Echocardiography (2007) 1.45
Chordal cutting technique through aortotomy: a new approach to treat chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2005) 1.43
Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia. Blood (2012) 1.43
Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J (2008) 1.40
An unusual case of papillary fibroelastoma "invading" the mitral valve. J Thorac Cardiovasc Surg (2006) 1.38
Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail (2008) 1.26
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
Staged repair of pectus excavatum during an aortic valve-sparing operation. J Thorac Cardiovasc Surg (2011) 1.23
A novel ADP/ATP transporter in the mitosome of the microaerophilic human parasite Entamoeba histolytica. Curr Biol (2005) 1.14
Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Stroke (2003) 1.14
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail (2014) 1.13
Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol (2003) 1.12
The "thymopericardial fat flap": a versatile flap in thoracic and cardiovascular surgery. J Thorac Cardiovasc Surg (2010) 1.11
Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. Nephrol Dial Transplant (2011) 1.10
The bone marrow--cardiac axis of myocardial regeneration. Prog Cardiovasc Dis (2007) 1.10
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care (2011) 1.09
Images in cardiovascular medicine. Coronary thrombosis and myocardial bridging. Circulation (2002) 1.09
Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF. JACC Cardiovasc Imaging (2013) 1.08
Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry. EuroIntervention (2014) 1.06
Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. Blood (2012) 1.06
Combined repair of pectus excavatum and cardiopulmonary bypass surgery. What is the best strategy? Ann Thorac Surg (2013) 1.06
Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart (2010) 1.05
Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol (2008) 1.03